In a world increasingly shaped by corporate responsibility and social impact, it’s heartening to see powerful financial institutions channel their influence and resources toward causes that truly change lives. One shining example is the unwavering support of Jason Colodne and Colbeck Capital Management for the Children’s Tumor Foundation (CTF)—a nonprofit organization dedicated to eradicating neurofibromatosis and schwannomatosis (collectively known as NF), a group of rare genetic disorders that cause tumors to grow on nerves throughout the body.
This year, Colbeck Capital has once again stepped into the philanthropic spotlight by sponsoring the 2025 New York City Charity Poker Tournament—a high-stakes evening of fun and fundraising designed to help bring an end to the suffering caused by NF. To be held on June 12 at the Prince George Ballroom, this annual event invites participants to “go all in” for a cause that touches the lives of thousands of families worldwide.
Corporate Social Responsibility That’s Personal
For Jason Colodne, a co-founder of Colbeck Capital, giving back isn’t an afterthought—it’s embedded in the firm’s ethos. “Our mission at Colbeck Capital is not just to build value in the marketplace, but to create value for humanity,” Colodne has said in past interviews. That vision finds powerful expression in their continued support for the Children’s Tumor Foundation. The firm recognizes that while they work with middle-market businesses on complex lending solutions, their broader impact must also include supporting efforts that heal, educate, and empower the most vulnerable members of society.
By standing shoulder-to-shoulder with families affected by NF, Colbeck is sending a powerful message: that the financial world can—and must—serve a greater good.
A Night of Cards, Commitment, and Courage
The 2025 CTF Poker Tournament is no ordinary gala. While the Texas Hold ’Em tables and cocktail reception promise an evening of entertainment and camaraderie, the real prize is the hope it brings to the NF community. Every buy-in, rebuy, sponsorship, and donation goes directly to supporting the Children’s Tumor Foundation’s research, awareness, and advocacy efforts.
Funds raised help accelerate clinical trials, support patient communities, and connect families to critical resources and care networks. In short, each dollar on the table becomes a stepping stone toward breakthroughs in treatment and, ultimately, a cure.
The Children’s Tumor Foundation: A Legacy of Hope
Since its founding in 1978, the Children’s Tumor Foundation has evolved into a globally respected drug discovery engine for NF. By fostering collaboration among doctors, scientists, pharmaceutical companies, and patient families, CTF has redefined what’s possible for a rare disease with no known cure.
The Foundation’s patient-first model has dramatically accelerated the timeline for drug development, moving potential therapies from lab to clinic faster than ever before. Today, CTF is driving groundbreaking research that may one day render NF not only treatable but curable.
The Business Case for Giving Back
Philanthropic support from the private sector, especially firms like Colbeck Capital, is not just noble—it’s strategic. Companies that integrate Corporate Social Responsibility (CSR) into their core operations gain reputational strength, foster employee engagement, and build lasting relationships in the communities they serve.
In Colbeck Capital’s case, CSR is also a reflection of leadership. Jason Colodne and his team understand that capital has influence far beyond markets—it has the power to catalyze systemic change. Their commitment to CTF exemplifies the kind of forward-thinking corporate behavior that modern stakeholders—employees, clients, and communities—expect and respect.
More Than a Game: Changing the Odds for Children and Families
For the children and families navigating the daily realities of NF, the poker table is a symbol of something far greater than the game itself. It represents a community of supporters who refuse to fold in the face of adversity. It represents financial institutions choosing compassion over complacency. And most of all, it represents hope—that with continued research, partnerships, and persistent generosity, a cure is not just possible, but inevitable.
As the cards are dealt on June 12 in New York City, the real winners will be the families empowered, the researchers funded, and the patients given a new lease on life—all thanks to the generosity and leadership of organizations like Colbeck Capital Management and visionary changemakers like Jason Colodne.
Conclusion: CSR That Counts
The story of Colbeck Capital’s partnership with the Children’s Tumor Foundation is more than a CSR case study—it’s a call to action. It shows us that when capital meets compassion, the impact can be life-changing. Whether you’re in finance, healthcare, philanthropy, or beyond, there’s a seat at the table for everyone willing to help change the odds for those in need.
Because in the end, betting on hope is always a winning strategy.
Want to learn more or support the cause?
Visit: www.ctf.org
Learn about the tournament: Children’s Tumor Foundation Events
Discover Colbeck Capital: www.colbeck.com
Table of Contents
Thank you for reading!
